Four and a half years after the COVID-19 pandemic altered the configuration of the U.S. workforce, Central Massachusetts employers are still navigating the reverberations of a landscape that changed overnight.
Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire Cortex, a California medical technology company working to advance the treatment of atrial fibrillation.Â
Massachusetts residents are poised to gain expanded access to follow-up breast cancer screenings and exams under a bill that is headed to Gov. Maura Healey's desk.
Leal Therapeutics has secured yet another multi-million financing deal as the Worcester-based biotechnology startup has raised $45 million to advance its therapeutics for individuals with central nervous system disorders.
In an effort to boost access to craniofacial care for children, Worcester healthcare provider UMass Memorial Health has teamed up with Fresh Start Surgical Gifts, a California-based medical nonprofit.
The sale of Steward Health Care's physician network to the Rural Healthcare Group has been finalized, the buyer announced Thursday along with a new name for the consolidated company: Revere Medical.
Justin Precourt, interim president of Worcester’s UMass Memorial Medical Center, has officially shed his provisional title, assuming his role as president of the largest hospital in Central Massachusetts.Â
As the biomanufacturing sector continues to expand into a wide range of applications, billions of dollars are being spent on biomedical research, targeting diseases and improving patient outcomes with technology.